T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (297)	11/2/2000 10:04:12 AM
From: BulbaMan	Read Replies (1) of 2243

Rick: You didn't seem interested when I previously mentioned SMDX (SpectruMedix), but I'll take a shot that you changed your mind. With a market-cap of about $8 million, becoming a 100-bagger would only bring it to $800 million – which, as we know, is no big deal these days. On the other hand, it's not that far down from $8 million to $0. Here's a blurb on SMDX from their latest press release: " SpectruMedix develops and manufactures high-speed and high throughput DNA sequencing and genetic analysis instrumentation for the acquisition, analysis and management of complex genetic information and high-throughput screening, massive parallel capillary electrophoresis systems for drug discovery. The DNA sequencing and high-throughput screening instrumentation were developed in part from research efforts conducted at the U.S. Department of Energy's Ames Laboratory, which is operated by Iowa State University's Institute for Physical Research and Technology. SpectruMedix is also involved in the development of instrumentation and methodology to rapidly assess lung function in all pulmonary diseases, in order to improve evaluation, diagnosis and treatment in such patients."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next